6533b833fe1ef96bd129ca2a

RESEARCH PRODUCT

Additional file 3: Figure S1. of Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial

Christopher PapandreouMònica BullòFrancisco TinahonesMiguel Martínez-gonzálezDolores CorellaGeorgios FragkiadakisJosé López-mirandaRamon EstruchMontserrat FitóJordi Salas-salvadó

subject

description

Principal component analysis (PCA) model to discriminate between the three baseline states in groups 1, 2 and 3. Model diagnostics (A = 8, R2X = 0.651, Q2X = 0.264) (DOCX 43 kb)

https://dx.doi.org/10.6084/m9.figshare.c.3870565_d5